Abcore Announces a Panel of Patent Pending Functional Single Domain Antibodies for Use as Therapeutic Candidates for Treatment of COVID-19

SAN DIEGO–(BUSINESS WIRE)–Abcore, Inc., a leader in contract research and development of single domain antibodies announced a panel of functional therapeutic candidates they have discovered and tested for the treatment of Coronavirus Disease 2019 (COVID-19). Abcore has demonstrated these therapeutic candidates bind to the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and functionally block binding to the Angiotensin Converting Enzyme-2 (ACE2) receptor. Single d